Showing results (1141-1150 of 1,228) with videos related to

Sort By:
Pageof 123
Neuroimage. Clinical|June 7, 2020
Disturbances across whole brain networks during reward anticipation in an abstinent addiction populationLiam J Nestor, John Suckling, Karen D Ersche, et al.
Biological Psychiatry Global Open Science|February 6, 2025
Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 LevelsFabiana Corsi-Zuelli, Gary Donohoe, Siân Lowri Griffiths, et al.
Psychopharmacology|February 26, 2016
Impulsivity in abstinent alcohol and polydrug dependence: a multidimensional approachEleanor M Taylor, Anna Murphy, Venkat Boyapati, et al.
The Australian and New Zealand Journal of Psychiatry|October 23, 2020
Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trialsRobson Zazula, Muhammad Ishrat Husain, Mohammadreza Mohebbi, et al.
Resuscitation|October 21, 2025
European Resuscitation Council Guidelines 2025 Adult Advanced Life SupportJasmeet Soar, Bernd W Böttiger, Pierre Carli, et al.
Human Molecular Genetics|January 30, 2022
Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositisClaire T Deakin, John Bowes, Lisa G Rider, et al.
Journal of Psychopharmacology (Oxford, England)|October 6, 2016
The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI descriptionJohn McGonigle, Anna Murphy, Louise M Paterson, et al.
Brain, Behavior, and Immunity|July 9, 2023
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneityParis Alexandros Lalousis, Lianne Schmaal, Stephen J Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphomaA J Davies, A Z S Rohatiner, S Howell, et al.
Pageof 123